Cited by 11Nanoplatforms for cancer theranosticsPhotodynamic Therapy Research StudiesLuminescence and Fluorescent Materials

Thienothiophene‐Benzopyran Derivative and AQ4N‐Assembled Liposomes for Near‐Infrared II Fluorescence Imaging‐Guided Phototherapy, Chemotherapy, and Immune Activation

Open access
Tang, Yuanyu, Pan, Tangna, Pang, E, Zhao, Shaojing, Shen, Xingxing, Tan, Qiuxia, Zhu, Pan, He, Dan +3 more·2025·Small

Abstract

Phototherapy, including photodynamic therapy (PDT) and photothermal therapy (PTT), has attracted wide attention in tumor treatment. However, the hypoxic tumor microenvironment and the heat shock proteins produced by tumor cells significantly reduce their efficacy. Developing effective phototherapy agents that have high reactive oxygen species generation efficiency and photothermal conversion efficiency (PCE) while simultaneously utilizing the hypoxic tumor microenvironment is of great importance. Here, a thienothiophene‐benzopyran derivative, BTPIC4F‐C10 is designed and synthesized, with near‐infrared (NIR) absorption and fluorescence. Then the lipid nanoparticles (LipBFCA NPs) which encapsulated BTPIC4F‐C10 in a phospholipid bilayer together with hypoxia‐activated prodrug banoxanthrone (AQ4N) are constructed for NIR‐II fluorescence imaging‐guided synergistic PDT/PTT/chemotherapy and immune activation. Under 808 nm laser irradiation, LipBFCA NPs is a high singlet oxygen quantum yield of 20.2% and PCE of 78.8%. With ultra‐high photon energy utilization efficiency of 99%, LipBFCA NPs is an excellent phototherapy effect. The hypoxic environment caused by phototherapy can further activate AQ4N to transform into chemically toxic AQ4 radicals to kill tumor cells. Moreover, phototherapy can induce immunogenic cell death, release tumor‐associated antigens, and activate immune responses. This work provides a new way for the clinical application of fluorescence imaging in guiding tumor diagnosis and treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/smll.202407680

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cyano derivatives such as malononitrile are essential electron acceptors for designing NIR-II fluorescent probes.

    “Cyano derivatives, such as malononitrile, are essential electron acceptors for designing NIR-II fluorescent probes”

    From Organic small-molecule NIR-II fluorophores for tumor phototheranostics (2026) · cites this paper as [190]

    In Results and Discussion (page not provided), the paper describes a malononitrile-containing chromophore as a strong electron-withdrawing component of its fluorescent molecule. This supports its use as an electron acceptor in this design, but the paper does not establish that cyano derivatives are essential for NIR-II fluorescent probes generally. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

3 of the 23 references couldn’t be matched to a known paper.

Research works printed but not linked: 16

  1. G. Wang, B. Li, L. Wu, J. Mater. Chem. A 2022, 10, 21884.
  2. X. He, Y. Lv, Y. Lin, H. Yu, Y. Zhang, Y. Tong, C. Zhang, Adv. Mater. 2024, 36, 2400366.
  3. Y. Zhu, Y. Wang, G. R. Williams, L. Fu, J. Wu, H. Wang, R. Liang, X. Weng, M. Wei, Adv. Sci. 2020, 7, 2000272.
  4. X. Cui, Q. Ruan, X. Zhuo, X. Xia, J. Hu, R. Fu, Y. Li, J. Wang, H. Xu, Chem. Rev. 2023, 123, 6891.
  5. X. Xie, K. Wang, J. Zeng, M. Xu, X. Qu, Z. Xiang, F. Tou, S. Huang, X. Han, J. Nanobiotechnol. 2023, 21, 497.
  6. K. Fan, L. Zhang, Q. Zhong, Y. Xiang, B. Xu, Y. Wang, J. Mater. Chem. B 2024,12, 5140.
  7. S. Liu, X. Zhou, H. Zhang, H. Ou, J. Lam, Y. Liu, L. Shi, D. Ding, B. Tang, J. Am. Chem. Soc. 2019, 141, 5359.
  8. L. Zhao, M. Chang, Z. He, Y. Zhao, J. Wang, Y. Lu, ACS Appl. Polym. Mater. 2023, 5, 1530.
  9. P. Yang, Y. Xu, X. Zhi, R. Li, B. Wang, R. Liu, Z. Dai, L. Qian, ACS Nano. 2024, 18, 12933.
  10. L. Yang, Y. Zhu, L. Liang, C. Wang, X. Ning, X. Feng, Nano Lett. 2022, 22, 4207.
  11. L. Galluzzi, E. Guilbaud, D. Schmidt, G. Kroemer, F. Marincola, Nat. Rev. Drug Discovery. 2024, 23, 445.
  12. S. Eckard, A. Sarde, L. Mei, C. Ruegg, P. Chun, V. Smith, Cancer Res. 2021, 81, 528.
  13. Z. Cao, S. Yang, B. Wang, X. Shen, G. Han, Y. Yi, J. Mater. Chem. A 2020, 8, 20408.
  14. G. Han, Y. Guo, X. Ma, Y. Yi, Sol. RRL 2018, 2, 1800190.
  15. S. Grimme, J. Antony, S. Ehrlich, H. Krieg, J. Chem. Phys. 2010, 132, 154104.
  16. G. Han, Y. Yi, J. Phys. Chem. Lett. 2019, 10, 2911.

Cited by

Sorted by citations

Authors
Tang, Y., Pan, T., Pang, E., Zhao, S., Shen, X., Tan, Q., Zhu, P., He, D., Wang, B., Song, X., & Lan, M.
Affiliations
  • Central South University (CN)
  • Hebei Normal University of Science and Technology (CN)
Corresponding author
  • He, Dan
  • Lan, Minhuan
Venue
Small
Publisher
Wiley
Published
2024-11-20
Volume
21
Issue
3
Pages
e2407680-e2407680
ISSN
  • 1613-6810 (ISSN-L)
  • 1613-6829
OpenAlex
W4404602339
Cited by
10
References
23
Citations by year
2026: 4 · 2025: 6
FWCI
1.10
Type
journal article
Language
en
Open access
Locations
  • Small (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (62375289, 62175262, 52272056)
  • National Key Research and Development Program of China (2022YFA1207600)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Photodynamic Therapy Research Studies
  • Physical Sciences › Materials Science › Materials Chemistry › Luminescence and Fluorescent Materials
Keywords
AQ4N, liposomes, NIR-II fluorescence imaging, photodynamic therapy, photothermal therapy, photothermal conversion efficiency, singlet oxygen generation, hypoxic tumor microenvironment, hypoxia-activated prodrug, near-infrared absorption
MeSH terms
Animals, Benzopyrans, Humans, Infrared Rays, Liposomes, Photochemotherapy, Phototherapy, Thiophenes, Xanthones, Cell Line, Tumor, Mice, Nanoparticles, Optical Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review